ArticleBioprocess and biosystems engineering2024
Bio-fabrication of silver nanoparticles using Commelina erecta, L.: a mechanistic approach on synthesis, optimization, antibacterial, and antioxidant potential.
Article in Bioprocess and biosystems engineering, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 8 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
The ongoing exploration of economical, sustainable, and environment-friendly methods for synthesizing monodisperse colloidal metal nanoparticles is growing day by day due to their potential application in various fields. The use of plant derivatives in nanoparticle synthesis and their suitability as sustainable catalysts have emerged as significant areas of research. In this study, silver nanoparticles were synthesized using an aqueous extract obtained from the commonly found weed Commelina erecta, L. Extensive study is conducted to optimize various synthesis parameters such as pH, reducing agent concentration, silver nitrate concentration, and temperature. The plant extract utilized in the synthesis process contained variety of antioxidants, including malic acid, phenol, benzoic acid, and catechol, which played a crucial role in both reduction and capping during the synthesis process, thereby making them suitable for biomedical applications. The optimized synthesis process yielded silver nanoparticles with a particle size of 16.2 ± 3.1 nm. These nanoparticles exhibited excellent stability and demonstrated remarkable antibacterial activity compared to the standard antibacterial agent, streptomycin. In addition, the silver nanoparticles displayed promising antioxidant activity attributed to the presence of antioxidant functional groups on their surface. This study reports, for the first time, the synthesis of silver nanoparticles using antioxidant compounds present in C. erecta, L. plant extract. The antioxidant compounds identified through GC-MS belong to phenols, phenolic acids, and carboxylic acid groups. Furthermore, the exceptional antimicrobial and antioxidant properties exhibited by the synthesized silver nanoparticles offer new possibilities for their potential applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.